• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

PEMBROLIZUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CD4 CELL PROLIFERATION IL23A PARKINSON DISEASE INFLAMMATION DIABETES MELLITUS CANCER SOD1 CLOSTRIDIUM DIFFICILE CELL DIFFERENTIATION ANGIOGENESIS ALZHEIMER'S DISEASE REMICADE BREAST CANCER RHEUMATOID ARTHRITIS CELL DEATH TNF LISTERIA MONOCYTOGENES PORPHYROMONAS GINGIVALIS METFORMIN HELICOBACTER PYLORI IFNG ESCHERICHIA COLI APOPTOTIC PROCESS AUTOPHAGY CELL DIVISION RECEPTOR TH17 CELLS STREPTOCOCCUS PNEUMONIAE IL6 INSULIN IL17A STAPHYLOCOCCUS AUREUS CTLA4 CASP3 NEURODEGENERATIVE DISORDERS FOXP3 PSEUDOMONAS AERUGINOSA ERBB-2 DOXORUBICIN CANDIDA ALBICANS TP53 AGING IMMUNE RESPONSE

© 2019 Biovista Vizit All Rights Reserved.